Oncology
 |
|
11 december 2019 18:00:02 |
| p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53 (Oncogene) |
|
Tweet |
| 219 viewsCategory: Oncology |
 Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer (Future Oncology)CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
